Family Legacy Inc. purchased a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,252 shares of the pharmacy operator’s stock, valued at approximately $768,000.
Several other institutional investors have also recently bought and sold shares of WBA. Forbes J M & Co. LLP raised its position in shares of Walgreens Boots Alliance by 7.4% in the fourth quarter. Forbes J M & Co. LLP now owns 2,908 shares of the pharmacy operator’s stock worth $240,000 after buying an additional 200 shares in the last quarter. LeJeune Puetz Investment Counsel LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $767,000. Independent Advisor Alliance bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $1,589,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $237,000. Finally, Lebenthal Asset Management LLC raised its position in shares of Walgreens Boots Alliance by 0.5% in the fourth quarter. Lebenthal Asset Management LLC now owns 115,317 shares of the pharmacy operator’s stock worth $9,544,000 after buying an additional 629 shares in the last quarter. Institutional investors and hedge funds own 61.17% of the company’s stock.
Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded down 1.88% during trading on Thursday, hitting $79.75. 4,719,786 shares of the company traded hands. The stock has a market capitalization of $85.34 billion, a PE ratio of 20.14 and a beta of 1.25. The company has a 50-day moving average of $78.96 and a 200-day moving average of $82.30. Walgreens Boots Alliance, Inc. has a 52-week low of $75.18 and a 52-week high of $89.69.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.30 by $0.03. The firm had revenue of $30.12 billion during the quarter, compared to the consensus estimate of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The firm’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same period in the prior year, the company posted $1.18 earnings per share. Equities analysts expect that Walgreens Boots Alliance, Inc. will post $5.01 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 18th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.01%. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend is Wednesday, August 16th. Walgreens Boots Alliance’s dividend payout ratio is 37.78%.
Walgreens Boots Alliance announced that its board has authorized a stock buyback plan on Thursday, June 29th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the pharmacy operator to purchase up to 5.9% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s management believes its shares are undervalued.
TRADEMARK VIOLATION WARNING: “Family Legacy Inc. Acquires New Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)” was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://stocknewstimes.com/2017/08/11/family-legacy-inc-purchases-new-position-in-walgreens-boots-alliance-inc-nasdaqwba-updated-updated.html.
A number of equities analysts recently weighed in on the stock. Zacks Investment Research lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Wednesday, June 14th. BidaskClub raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Thursday, August 3rd. Jefferies Group LLC decreased their price target on shares of Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, May 31st. Needham & Company LLC set a $94.00 price target on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Monday, July 17th. Finally, Guggenheim reaffirmed a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have assigned a buy rating to the stock. Walgreens Boots Alliance currently has a consensus rating of “Buy” and an average target price of $90.69.
In related news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the transaction, the director now directly owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 13.50% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
